system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, METHODS, RESULTS. Meshes: Biomarkers, Tumor, Carcinoma, Papillary, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Lymphatic Metastasis, Male, Middle Aged, Muscle Neoplasms, NIMA-Interacting Peptidylprolyl Isomerase, Neoplasm Invasiveness, Neoplasm Staging, Prognosis, Thyroid Neoplasms.
user
Is pin1 related with clinical stage of papillary thyroid carcinoma? Context: The context and aim of this article was to investigate whether the expression level of Pin1 was in association with the clinical stage of papillary thyroid carcinomas. Seventy-two patients who had been treated at the Affiliated Hospital of Qingdao University - Yantai YuHuangDing Hospital during January 2013 to December 2014 were rolled in. The expression levels of Pin1 using immunohistochemistry were tested and were divided into four groups according to the different clinical stages and final scores based on multiplying intensity and percentage value of IHC results. Data was analyzed with SPSS 20.0, and P value <0.05 had been chosen as significant. Considered from analysis result, the Pin1 expression status statistically significantly correlated with the PTC clinical stages (χ(2) = 8.128, P = 0.043); as the clinical stage proceeded, the intensity of Pin1 in PTC cells had been increased. But we did not find any relationships between immunohistochemical staining results and other clinicopathological characteristics.
assistant
The PTC cells' intensity of Pin1 was in association with the clinical stage. The role played by Pin1 in PTC has been studied, and we need to further investigate the application of Pin1 in the treatment of PTC. Final Decision: yes